{"schema_version":"alpha-profile-public-v1","slug":"kenneth-hoberman","canonical_url":"https://registry.alpha.ac/people/kenneth-hoberman","as_of":"2026-09-22T04:18:27.470702+00:00","published_at":"2026-09-02T02:37:23.851244+00:00","last_reviewed_at":"2026-05-16T06:12:56.385+00:00","identity":{"display_name":"Kenneth Hoberman","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Nuvectis Pharma, Inc.","company_slug":"nuvectis-pharma-inc","exchange":"NASDAQ","ticker":"NVCT","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","effective_date":"2025-04-28","last_checked_at":"2026-04-28T23:42:02.059+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=kenneth-hoberman","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=kenneth-hoberman&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Joined Board in July 2021 with extensive financial, investor relations, corporate governance and business development experience. Served as COO of Stemline Therapeutics since 2013, leading the company through IPO and acquisition by Menarini Group."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Nuvectis Pharma, Inc.","organizationId":"nuvectis-pharma-inc","title":"Director","period":"2021-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm"},{"organization":"TG THERAPEUTICS, INC.","organizationId":"tg-therapeutics-inc","title":"Director","period":"2014-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Nuvectis Pharma, Inc.","company_slug":"nuvectis-pharma-inc","exchange":"NASDAQ","ticker":"NVCT","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","effective_date":"2025-04-28","last_checked_at":"2026-04-28T23:42:02.059+00:00"}},{"company_name":"TG THERAPEUTICS, INC.","company_slug":"tg-therapeutics-inc","exchange":"NASDAQ","ticker":"TGTX","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2014-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","effective_date":"2025-04-30","last_checked_at":"2026-05-03T19:25:02.108+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Kenneth Hoberman as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:30:56.747727+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NVCT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T01:30:56.610118+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Executive extraction classified AI/ML experience for Kenneth Hoberman as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:12:56.58054+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NVCT 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","published_at":"2026-02-11T00:00:00+00:00","last_checked_at":"2026-05-16T06:12:56.440736+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Kenneth Hoberman currently serves as Director at TG Therapeutics.","claim_state":"verified","valid_from":"2025-04-30","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T19:25:36.706702+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TGTX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-03T19:25:36.606288+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Kenneth Hoberman currently serves as Director at Nuvectis Pharma, Inc..","claim_state":"verified","valid_from":"2025-04-28","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:30:56.695923+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NVCT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T01:30:56.610118+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit","Compensation"],"claim_text":"Kenneth Hoberman serves on Audit, Compensation.","claim_state":"verified","valid_from":"2025-04-30","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T19:25:36.732816+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TGTX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","published_at":"2025-04-30T00:00:00+00:00","last_checked_at":"2026-05-03T19:25:36.606288+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit","Compensation"],"claim_text":"Kenneth Hoberman serves on Audit, Compensation.","claim_state":"verified","valid_from":"2025-04-28","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:30:56.720991+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NVCT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T01:30:56.610118+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Stemline Therapeutics, Inc.","claim_text":"Kenneth Hoberman is linked to Stemline Therapeutics, Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:30:56.890959+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NVCT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T01:30:56.610118+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Operating Officer","claim_text":"Kenneth Hoberman is also listed as Chief Operating Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:30:56.86924+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NVCT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T01:30:56.610118+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Kenneth Hoberman as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:30:56.795513+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NVCT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T01:30:56.610118+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for Kenneth Hoberman as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:12:56.616931+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NVCT 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","published_at":"2026-02-11T00:00:00+00:00","last_checked_at":"2026-05-16T06:12:56.440736+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Nuvectis Pharma, Inc.","claim_text":"Kenneth Hoberman is associated with Nuvectis Pharma, Inc..","claim_state":"verified","valid_from":"2026-02-11","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:12:56.564386+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NVCT 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","published_at":"2026-02-11T00:00:00+00:00","last_checked_at":"2026-05-16T06:12:56.440736+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Director","claim_text":"Kenneth Hoberman is listed as Director at Nuvectis Pharma, Inc..","claim_state":"verified","valid_from":"2026-02-11","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:12:56.544882+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NVCT 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","published_at":"2026-02-11T00:00:00+00:00","last_checked_at":"2026-05-16T06:12:56.440736+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"other_company_role","claim_value":{"role":"Chief Operating Officer","company":"Stemline Therapeutics, Inc."},"claim_text":"Kenneth Hoberman is also linked to Stemline Therapeutics, Inc. as Chief Operating Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.7,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:12:56.652955+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NVCT 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","published_at":"2026-02-11T00:00:00+00:00","last_checked_at":"2026-05-16T06:12:56.440736+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Kenneth Hoberman as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:30:56.77155+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NVCT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","published_at":"2025-04-28T00:00:00+00:00","last_checked_at":"2026-05-16T01:30:56.610118+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":true,"claim_text":"Executive extraction classified technology background for Kenneth Hoberman as true.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T06:12:56.59938+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NVCT 10-K executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","published_at":"2026-02-11T00:00:00+00:00","last_checked_at":"2026-05-16T06:12:56.440736+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:kenneth-hoberman","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2021-01-01 · current","organization":"Nuvectis Pharma, Inc.","organization_id":"nuvectis-pharma-inc"},"claim_text":"Director at Nuvectis Pharma, Inc. (2021-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1},{"subject":"alpha:person:kenneth-hoberman","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2014-01-01 · current","organization":"TG THERAPEUTICS, INC.","organization_id":"tg-therapeutics-inc"},"claim_text":"Director at TG THERAPEUTICS, INC. (2014-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/kenneth-hoberman#profile","url":"https://registry.alpha.ac/people/kenneth-hoberman","dateModified":"2026-05-16T06:12:56.385+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/kenneth-hoberman#person","name":"Kenneth Hoberman","url":"https://registry.alpha.ac/people/kenneth-hoberman","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Nuvectis Pharma, Inc.","tickerSymbol":"NASDAQ: NVCT"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","memberOf":{"@type":"Organization","name":"Nuvectis Pharma, Inc.","url":"https://registry.alpha.ac/companies/nuvectis-pharma-inc","tickerSymbol":"NASDAQ: NVCT"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2014-01-01","memberOf":{"@type":"Organization","name":"TG THERAPEUTICS, INC.","url":"https://registry.alpha.ac/companies/tg-therapeutics-inc","tickerSymbol":"NASDAQ: TGTX"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","name":"NVCT DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","name":"NVCT 10-K executive officers"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","name":"TGTX DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/kenneth-hoberman"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":11,"corroborated":4,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":15,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":7,"distinct_source_count":3,"conflicts":[{"claim_type":"technology_background","kind":"extraction_disagreement","headline":false,"review_route":"internal_review","values":["false","true"],"publishers":["SEC EDGAR"],"source_types":["sec_filing"],"rationale":"Pipeline extraction runs disagree over documents from one publisher; routed to internal review, not headlined."}],"conflict_count":1,"headline_conflict_count":0,"internal_review_conflict_count":1,"contradiction_types":["technology_background"],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":11,"corroborated":4,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":15,"corroborated_claims":4,"sources":7,"distinct_sources":3,"role_claims":2,"last_reviewed_at":"2026-05-16T06:12:56.385+00:00","observed_at":"2026-09-22T04:18:27.470702+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"kenneth-hoberman","canonical_url":"https://registry.alpha.ac/people/kenneth-hoberman"},"publication":{"published_at":"2026-09-02T02:37:23.851244+00:00","last_reviewed_at":"2026-05-16T06:12:56.385+00:00","as_of":"2026-09-22T04:18:27.470702+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/kenneth-hoberman","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/kenneth-hoberman","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/kenneth-hoberman.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}